Guide to Drug Financing Mechanisms
(1998; 64 pages) [French] [Spanish]
Table of Contents
View the documentForeword
View the documentAcknowledgements
Open this folder and view contentsIntroduction
Open this folder and view contentsChapter 1. Selection
Close this folderChapter 2. Procurement
Open this folder and view contentsObjective of procurement
Open this folder and view contentsProcurement strategies
Close this folderOrganization and structures
View the documentCentralized or decentralized organization?
View the documentMonopoly or competition for procurement?
View the documentPublic or private structures?
View the documentProcurement: important points
Open this folder and view contentsChapter 3. Distribution
Open this folder and view contentsChapter 4. Prescribing
Open this folder and view contentsSummary: contributions and limitations of the economic approach
View the documentReferences
View the documentSelected WHO publications of related interest
View the documentBack cover
 

Public or private structures?

Both public and private procurement bodies can perform equally well. They must be have clear and well-thought-out specifications, and these specifications must be effectively enforced by a body independent of the procurement agency (such as the government). However, if private procurement enterprises are much more difficult to control than public ones, social and public health objectives may be neglected. Privatizing procurement will have far-reaching effects, for it is easier in today’s international context to move from public to private status, or to adopt a policy of deregulation, than to reverse these actions.

to previous section to next section
 

Last updated: May 3, 2013